Processes for the preparation of a diarylthiohydantoin compound
US-10723714-B2 · Jul 28, 2020 · US
Process for the preparation of a diarylthiohydantoin compound
US11040953B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11040953-B2 |
| Application number | US-202016939976-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 27, 2020 |
| Priority date | Dec 19, 2014 |
| Publication date | Jun 22, 2021 |
| Grant date | Jun 22, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
First claim
Opening claim text (preview).
The invention claimed is: 1. A process for preparing compound 1c: the method comprising converting compound VII to compound 1c: 2. The process of claim 1 comprising: reacting compound VII with an organomagnesium halide; in the presence or absence of a lithium halide; and adding carbon dioxide gas; in an aprotic organic solvent; at a temperature of about 0° C. to yield compound 1c. 3. The process of claim 1 , comprising reacting compound VII under a carbon monoxide atmosphere; in the presence of a palladium catalyst; in the presence of one or more phosphorus ligands; in the presence of water; in a solvent; at a temperature of about 0° C. to about 100° C. to yield the compound 1c.
Assignees
Inventors
Classifications
with a four-membered ring · CPC title
Nitriles · CPC title
condensed with carbocyclic rings or ring systems · CPC title
of the prostate · CPC title
Halogen atoms or nitro radicals · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11040953B2 cover?
- Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
- Who is the assignee on this patent?
- Aragon Pharmaceuticals Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D401/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).